To date, NDR has obtained CE certification and has applied for FDA approval for the ANT system. In 2021, the company made its debut in the Chinese market by entering into a joint venture agreement with China’s MicroPort to commercialize the system. As the Japanese market is a valuable market, NDR will soon begin its efforts to obtain regulatory approval from Japan’s PMDA for the product to be marketed in Japan.
With the world’s fastest aging population of 126 million, Japan is expected to be the second largest medical device market after the United States and is expected to grow at a compound annual growth rate (CAGR) of 4.6%, passing from $ 54.5 billion in 2018 to $ 74.7 billion in 2025. Therefore, NDR collaborated with Nagoya City University Graduate School of Medicine (Department of Nephrology and Urology) and completed two clinical trials of its flagship ANT system. Building on these successful trials, the company aims to make Japan one of its key markets along with China and the United States.
The ANT system
NDR’s flagship Automated Needle Technology (ANT) system is the world’s first AI-based interventional robotic system, and it is transforming the way clinicians perform interventional procedures by ensuring precise and safe insertion of the needle. needle during surgery. The core technology is based on the lightweight robot specially designed for medical and AI that transforms real-time image analyzes into precise robotic movements. ANT has the potential to enable surgeons of all levels of expertise to easily perform complex and high-risk surgeries.
About NDR Medical Technology Pte. Ltd.
NDR Medical Technology is a surgical robotics company established on October 14, 2014. It specializes in the development and production of AI-based interventional robotic systems that seek to revolutionize the surgical arena. Led by CEO Alan Goh, the company has made great strides towards improving the medical landscape with AI and medical imaging.
About REAL TECH FUND
REAL TECH FUND is a venture capital fund managed by Real Tech Holdings and a subsidiary of Real Tech Japan. It invests in deep-tech start-ups solving societal and environmental problems. The real tech fund also brings knowledge and know-how to ensure the success of its investments.
Official name: Real Tech Fund 1 Investment Limited Partnership (A), Real Tech Fund 2 Investment Limited Partnership (A), Real Tech Fund 3 Investment Limited Partnership (A), Real Tech Global Fund 1 Investment Business Partnership (B)
General Partner: (A) Real Tech Japan LLC
Operating Partner: (B) Real Tech Holdings Co., Ltd.
About Real Tech Holdings Co., Ltd.
Real Tech Holdings is a joint venture between Euglena Co., Ltd. and Leave a Nest Co., Ltd. It supports the agents of change who give themselves body and soul to solve societal and environmental challenges.